参考文献/References:
[1] GUENETTE M D,CHINTOH A,REMINGTON G,et al.Atypical antipsychotic-induced metabolic disturbances in the elderly[J].Drugs Aging,2014,31(3):159-184.
[2] CITROME L,HOLT R I,WALKER D J,et al.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder[J].Clin Drug Investig,2011,31(7):455-482.
[3] ZHANG Y,CHEN M,CHEN J,et al.Metabolic syndrome in patients taking clozapine:prevalence and influence of catechol-O-methyltransferase genotype[J].Psychopharmacology (Berl),2014,231(10):2211-2218.
[4] KRAEMER S,MINARZYK A,FORST T,et al.Prevalence of metabolic syndrome in patients with schizophrenia,and metabolic changes after 3 months of treatment with antipsychotics-results from a German observational study[J].BMC Psychiatry,2011,11:173.
[5] GRUNDY S M,BREWER H B JR,Cleeman J I,et al.Definition of metabolic syndrome:report of the National Heart,Lung,and Blood Institute/American Heart Association conference on scientific issues related to definition[J].Circulation,2004,109(3):433-438.
[6] BAPTISTA T,MARTINEZ J,LACRUZ A,et al.Metformin for prevention of weight gain and insulin resistance with olanzapine:a double-blind placebo-controlled trial[J].Can J Psychiatry,2006,51(3):192-196.
[7] 范肖冬,汪向东.ICD-10精神与行为障碍分类[M].北京.人民卫生出版社,1993:72-89.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南:2013年版[J].中国糖尿病杂志,2014,22(8):2-42.
[9] HAUPT D W,NEWCOMER J W.Abnormalities in glucose regulation associated with mental illness and treatment[J].J Psychosom Res,2002,53(4):925-933.
[10] REEVES G M,KEETON C,CORRELL C U,et al.Improving metabolic parameters of antipsychotic child treatment (IMPACT) study:rationale,design,and methods[J].Child Adolesc Psychiatry Ment Health,2013,7(1):31.
[11] GUPTA A,DADHEECH G,YADAV D,et al.Metabolic issues in schizophrenic patients receiving antipsychotic treatment[J].Indian J Clin Biochem,2014,29(2):196-201.
[12] 高学敏.中药学[M].北京:中国中医药出版社,2003:244-507.
[13] 柯斌,师林,张俊杰,等.加味苓桂术甘汤联合短期禁食治疗肥胖型糖耐量异常的临床研究[J].中药材,2012,35(5):843-845.
[14] 黄江荣,杜亚明,鄢进,等.加味苓桂术甘汤对代谢综合征大鼠血清抵抗素、脂联素、胰岛素、胰岛素抵抗的影响[J].中国实验方剂学杂志,2013,19(6):227-230.
[15] 黄江荣,李祥华,杜亚明,等.加味苓桂术甘汤对代谢综合征大鼠糖代谢的影响[J].中药药理与临床,2013,29(3):167-169.
[16] 汪园园,金明华,柯斌,等.苓桂术甘汤联合热量限摄对胰岛素抵抗模型大鼠的影响及机制研究[J].中国中西医结合杂志,2013,33(3):356-360.
[17] 黄峰.加味苓桂术甘颗粒治疗酒精性脂肪肝痰瘀互结证30例[J].陕西中医,2012,33(2):180-182.
[18] 柯斌,师林,张俊杰,等.加味苓桂术甘汤联合短期禁食对脾虚痰湿型高脂血症患者血管内皮功能的保护作用[J].中国中医药科技,2012,19(3):207-209.
[19] 杜亚明,黄江荣,李祥华,等.加味苓桂术甘汤对代谢综合征大鼠体质量、血压和脂代谢的影响[J].中药药理与临床,2013,29(1):111-113.
[20] 蔡素华,吕俊华,唐言利,等.加味苓桂术甘汤对奥氮平诱导肥胖大鼠的减肥作用[J].中国医院药学杂志,2011,31(12):966-969.
相似文献/References:
[1]王淑红,金培印,可海霞,等.血清妊娠相关蛋白A水平对代谢综合征患者预后评价[J].新乡医学院学报,2008,25(06):605.
[2]可海霞,贾银明,韩勤甫,等.妊娠相关蛋白A及C-反应蛋白与代谢综合征的关系[J].新乡医学院学报,2008,25(01):071.
[3]丁世彬,张国富,吴卫东.环境内分泌干扰物与代谢综合征[J].新乡医学院学报,2015,32(02):101.[doi:10.7683/xxyxyxb.2015.02.003]
[4]朱宝琛,师 帅,王 欢,等.不同血压等级代谢综合征患者的血栓形成特征[J].新乡医学院学报,2016,33(7):613.[doi:10.7683/xxyxyxb.2016.07.017]
ZHU Bao-chen,SHI Shuai,WANG Huan,et al.Thrombogenesis character of metabolic syndrome patients with different level of hypertension[J].Journal of Xinxiang Medical University,2016,33(12):613.[doi:10.7683/xxyxyxb.2016.07.017]